CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 56,250 shares (grant or award)
- 4 Grant or award EVP & CHIEF BUSINESS OFFICER acquired 62,500 shares (grant or award)
- 4 Grant or award EVP & CHIEF SCIENTIFIC OFFICER acquired 62,500 shares (grant or award)
- 4 Grant or award EVP & CHIEF INNOVATION OFFICER acquired 62,500 shares (grant or award)
- 4 Grant or award EVP & CHIEF FINANCIAL OFFICER acquired 62,500 shares (grant or award)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 5,290 shares at $5.10 ($26,979)
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 7,851 shares at $5.11 ($40,119)
- 4 Open-market sale EVP & CHIEF SCIENTIFIC OFFICER sold 5,290 shares at $5.10 ($26,979)
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 7,857 shares at $5.11 ($40,149)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 6,225 shares at $5.10 ($31,748)
- 4 Open-market buy Director bought 4,115 shares at $5.02 ($20,657)
- 4 Open-market buy Director bought 33,000 shares at $4.19 ($138,270)
- 4 Open-market buy Director bought 4,115 shares at $4.47 ($18,394)
- 4 Open-market buy Director bought 822,613 shares at an average $4.38 ($3,600,784)
- 4 Open-market buy Director bought 1,500,000 shares at an average $3.37 ($5,055,000)
- 4 Open-market buy Director bought 4,115 shares at $3.17 ($13,045)
- 4 Open-market buy Director bought 4,115 shares at $3.05 ($12,551)
- 4 Open-market buy Director bought 4,115 shares at $2.09 ($8,600)
- 4 Open-market buy Director bought 4,115 shares at $2.43 ($9,999)
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,116 shares at $2.58 ($2,879)
Page 2 of 11 · 206 filings